History and evolution of reproductive and developmental toxicology guidelines

Current Pharmaceutical Design

Volumn 12, Issue 12, 2006, Pages 1449-1465

  Collins, Thomas F X ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Guidelines; Reproduction; Teratology

Indexed keywords

CHEMICAL COMPOUND; CHLORDECONE; CHLORPHENOTANE; ENDOCRINE DISRUPTOR; NEW DRUG; THALIDOMIDE; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; BIRTH DEFECT; DEVELOPMENTAL BIOLOGY; DRUG SCREENING; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; EXPOSURE; FERTILITY; FETUS DEVELOPMENT; FOOD CONTAMINATION; GENITAL SYSTEM FUNCTION; HISTOPATHOLOGY; HISTORY; HUMAN; NONHUMAN; OOCYTE; OVARY FUNCTION; PERINATAL DEVELOPMENT; POSTNATAL DEVELOPMENT; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PUBLICATION; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SEMEN ANALYSIS; SEXUAL BEHAVIOR; SIMULATION; TERATOLOGY; ANIMAL; DRUG EFFECT; REPRODUCTION; STANDARD; TOXICITY TESTING; TOXICOLOGY;

ANIMALS; GUIDELINES; HUMANS; REPRODUCTION; RISK ASSESSMENT; TOXICITY TESTS; TOXICOLOGY;

EID: 33745099965     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206776389813     Document Type: Review

References (52)

1. Barrow MV. A brief history of teratology to the early 20th century. Teratology 1971, 4: 119-30.
2. Hickey MF. Genes and mermaids: Changing theories of the causation of congenital abnormalities. Med J Austral 1953; 1: 649-67.
3. Goldstein L, Murphy DP. Etiology of die ill-health in children born after maternal pelvic irradiation. Amer J Roentgen Rad Ther 1929; 22: 322-31.
4. Job TT, Leibold GL, Fitzmaurice HA. Biological effects of roentgen rays. The determination of critical periods in mammalian development with X-rays. Amer J Anat 1935; 56: 97-117.
5. Hale F. Pigs born without eyeballs. J Hered 1933; 24: 105-6.
6. Hale F. The relation of vitamin A to anophthalmos in pigs. Amer J Ophthalmol 1935; 18: 1087-93.
7. Warkany J, Nelson RC. Appearance of skeletal abnormalities in the offspring of rats reared on a deficient diet. Science 1940; 92: 383-4.
8. Gregg N M. Congenital cataract following German measles in mothers. Trans Ophthalmol Soc Austral 1941; 3: 35-46.
9. Lenz W. Kindliche missbildungen nach medikament wahrend der Dravidatat? Deut Med Wochenschr 1961; 86: 2555-86.
10. McBride WG. Thalidomide and congenital abnormalities. Lancet 1961; 2: 1358.
11. Lehman AJ, Laug EP, Woodard G, Draize JH, Fitzhugh OG, Nelson AA. Procedures for the appraisal of the toxicity of chemicals in foods. Food Drug Cosmet Law J 1949; 4: 412.
12. Food and Drug Administration. Appraisal of the safety of chemicals in foods, drugs and cosmetics. US Food and Drug Administration, Division of Pharmacology. Published by the Association of Food and Drug Officials of the United States 1959.
13. President's Science Advisory Committee. Use of pesticides. Washington, DC, Government Printing Office 1963.
14. Fitzhugh OG. In: Boyland E. Goulding R Eds, Modern trends in toxicology. London, Butterworth, 1968; 1: 75-85.
15. Collins TFX. In: Wilson JG, Fraser FC Eds, Handbook of teratology. Now York, Plenum 1978; 4: 191-214.
16. Food and Drug Administration. Toxicological principles for the safety assessment of direct food additives and color additives used in food. Washington, DC, US Food and Drug Administration, Bureau of Foods 1982.
17. Christian MS. A review of multigeneration studies. J Amer Coll Toxicol 1986; 5: 161-80.
18. Francis EZ, Kimmel GL. Proceedings of the workshop on one- vs two-generation reproductive effects studies. J Amer Coll Toxicol 1988; 7: 911-25.
19. Food and Drug Administration. Toxicological principles for the safety assessment of direct food additives and color additives used in flood, Redbook II. Washington, DC, US Food and Drug Admmistration, Center for Food Safety and Applied Nutrition 1993.
20. Food and Drug Administration. Redbook 2000: Toxicological principles for the safety assessment of food ingredients. Washingon, DC, US Food and Drug Administration, Bureau of Foods, Center for Food Safety and Applied Nutrition DC, 2000. The latest edition is available on the FDA website http://www.cfsan.fda.gov.
21. Environmental Protection Agency. Reproduction and fertility effects. Health Effects Test Guidelines 1998; OPPTS 870.3800.
22. Organization for Ezonomic Cooperation and Development (OECD). Two generation reproduction toxicity study. OECD Guideline 416 for Testing of Chemicals 2001.
23. Collins TFX, Sprando RL, Hanson DL, Shackelford ME, Welsh JJ. Testing guidelines for evaluation of reproductive and developmental toxicity of food additives in females. Int J Toxicol 1998; 17: 299-325.
24. Frankos VH. FDA perspectives on the use of teratology data for human risk assessment Fund Appl Toxicol 1985: 5: 615-25.
25. Food and Drug Administration. Guidelines for reproduction studies for safety evaluation of drugs for human use. Washington, DC, FDA 1966; 5 pp.
26. Kelsey FO. In: Janerich DT, Skalko RG, Porter IH Eds, Congenital defects - new guidelines in research. New York, Academic Press 1974; 195-204.
27. WHO (World Health Organization) Scientific Group. Principles for the testing of drugs for toratogenicity. Report of a WHO scientfic group. World Health Organization Technical Report Series 1967; No. 364. Geneva, WHO.
28. Food and Drug Administration. Advisory Committee on Protocols for Safety Evaluation. Panel on Reproduction Report on Reproduction Studies in Safety Evaluation of Food Additives and Pesticide Residues. Toxicol Appl Pharmacol 1970; 16: 264-96.
29. Interagency Regulatory Liaison Group (IRLG). Recommended guidelines for teratogenicity studies in the rat, mouse, hamster, or rabbit Washington DC, IRLG Testing Standards and Guidelines Work Group, 1981.
30. Interagency Regulatory Liaison Group (IRLG). Interagency Regolatory Liaison Group Workshop on Reproductive Toxicity Risk Assessment Environ Hlth Pers 1986; 66: 193-221.
31. Shepard TH. Catalog of teratogenic agents. First Ed. Baltimore, Johns Hopkins University Press, 1973.
32. Shepard TH. Catalog of Teratogenic Agents. Fourth Ed. Baltimore, Johns Hopkins University Press, 1983.
33. Fraser FC. In: Wilson JG, Fraser FC Eds, Handbook of teratology. New York, Plenum Press 1977; 1: 75-96.
34. Code of Federal Regulations. CFR 1979; 21: 201.57.
35. Jackson BA. Buruea of Food Developmental Toxicity Guideline. A progress report presented at Tripartite Meeting, January 12, 1983.
36. Jackson BA. In: The Toxicology Forum, 1988 Annual Winter Meeting, February 22-24, 1988. Bethesda, The Toxicology Forum, Inc. 1988; 207-16.
37. Gad SC. Drag safety evaluation. Now York, John Wiley and Sons 2002; 258-96.
38. International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH). Detection of toxicity to reproduction fbr medicinal products 1993.
39. Food and Drug Administration. International conference on harmomisation; guideline to detection of toxicity to reproduction for medicinal products; availability Fed Reg 1994; 59: 48746-52.
40. Food and Drug Administration. International conference on harmonisation; guideline on detection of toxicity to reproduction for medicinal products; Addendum on toxicity to male fertility; availability. Fed Reg 1996; 61: 15360-1.
41. Kimmel C. In: An Evaluation and interpretation of reproductive endpoints for human health risk assessment Washington, DC, Int Life Sci Inst 1999; 3-4.
42. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during the past 50 years. Brit Med J 1992; 305:609-13.
43. Paulsen AR, Berman NG, Wang C. Data from men in greater Seattle area reveal no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fert Ster 1995; 65: 105-20.
44. Clark RL. In: An evaluation and interpretation of reproductive endpoints for human health risk assessment. Washington, DC, Int Life Sci Inst 1999; 10-27.
45. Cooper RL, Goldman JM. In: An evaluation and interpretation of reproductive endpoints for human health risk assessment. Washington, DC, Int Life Sci Inst 1999; 42-56.
46. Heindel JJ. In: An evaluation and interpretation of reproductive endpoints for human health risk assessment. Washington, DC, Int Life Sci Inst 1999; 57-74.
47. Chapin RE, Conner MW. In: An evaluation and interpretation of reproductive endpoints for human health risk assessment. Washington, DC, Int Life Sci Inst 1999; 28-41.
48. Sprando RL, Collins TFX. Testing guidelines for evaluation of food additives' effects on male reproduction. Int J Toxicol 1998: 17: 327-36.
49. Food and Drug Administration. Reviewer Guidance. Integration of study results to assess concerns about human reproductive and developmental toxicities. Rockville, MD, Center for Drug Evaluation and Research October 2001.
50. Dejucq-Rainsford N, Jegou B. Viruses in semen and male genital tissues - consequences for the reproductive system and therapeutic perspectives. Curr Pharm Des 2004, 10(5): 557-75.
51. Jawerbaum A, Gonzalez E. The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy. Curr Pharm Des 2005, 11(10): 1327-42.
52. Raijmakers MT, Peters WH, Steegers EA, Poston L. Amino thiols, detoxification and oxidative stress in pre-eclampsia and other disorders of pregnancy. Curr Pharm Des 2005; 11 (6): 711-34.